Circulatory Inflammatory Mediators in the Prediction of Anti-Tuberculous Drug-Induced Liver Injury Using RUCAM for Causality Assessment.

Cheng-Maw HoChi-Ling ChenChia-Hao Chang Meng-Rui Lee Ming-Chia LeeRey-Heng HuPo-Huang Lee

Published in: Biomedicines (2021)

Pre-treatment IL-22BP was a protective biomarker against DILI development under anti-TB treatment, and a score set by additional risk factors of IP-10 and sCD163 employed an adequate DILI prediction.

Keyphrases

risk factors
drug induced
mycobacterium tuberculosis
oxidative stress
emergency department
combination therapy
electronic health record
smoking cessation